Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies

Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies

US Patent 11999777 · Granted Jun 4, 2024

Estimated economic value: $102,637,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating atopic dermatitis by administering an IL-4R antagonist2025
Treatment of fibrodysplasia ossificans progressiva by administration of an anti-2025
Methods of treating allergy using anti-Bet v 1 antibodies2024
Methods of treating allergy using anti-Bet v 1 antibodies2024
Methods for treating or preventing asthma by administering an IL-4R antagonist2023
Therapeutic antibodies and their uses2023
Anti-EDB antibodies and antibody-drug conjugates2023
Methods for preventing or treating allergy by administering an IL-4R antagonist2023
Methods for treating skin infection by administering an IL-4R antagonist2023
Methods for treating allergy and enhancing allergen-specific immunotherapy by ad2022
Methods for treating allergy and enhancing allergen-specific immunotherapy by ad2022
Methods for altering body composition by administering a GDF8 inhibitor and an A2022